Cytokine Response in Autovaccine-Treated Patients with Chronic Infections

This study aims to describe the levels of circulating cytokines produced by Th lymphocytes (IFN-γ, IL-4, IL-10, IL-17A), as well as the levels of cytokines produced by monocytes/macrophages (TNF-α, IL-1β, IL-12), in patients with chronic Staphylococcus aureus infections before treatment and followin...

Full description

Bibliographic Details
Main Authors: A. Szkaradkiewicz, T.M. Karpiński, O. Goślińska-Pawłowska, A.K. Szkaradkiewicz, S. Giedrys-Kalemba
Format: Article
Language:English
Published: SAGE Publishing 2013-01-01
Series:European Journal of Inflammation
Online Access:https://doi.org/10.1177/1721727X1301100110
_version_ 1818527515533115392
author A. Szkaradkiewicz
T.M. Karpiński
O. Goślińska-Pawłowska
A.K. Szkaradkiewicz
S. Giedrys-Kalemba
author_facet A. Szkaradkiewicz
T.M. Karpiński
O. Goślińska-Pawłowska
A.K. Szkaradkiewicz
S. Giedrys-Kalemba
author_sort A. Szkaradkiewicz
collection DOAJ
description This study aims to describe the levels of circulating cytokines produced by Th lymphocytes (IFN-γ, IL-4, IL-10, IL-17A), as well as the levels of cytokines produced by monocytes/macrophages (TNF-α, IL-1β, IL-12), in patients with chronic Staphylococcus aureus infections before treatment and following completion of autovaccine treatment. The study was carried out on adult individuals, including 25 healthy subjects (group 1, control, not treated), 50 patients with chronic suppurative dermatitis (group 2) and 40 patients with chronic infections of the upper respiratory tract (group 3). Blood serum cytokine levels were measured by enzyme–linked immunosorbent assay (ELISA). S. aureus was detected in cultures of suppurative dermal exudates or of pharyngeal smears. For every individual patient an autovaccine was prepared, containing a suspension of inactivated S. aureus bacteria (1.5 × 10 8 bacteria/ml) isolated from the patient. The autovaccine was administered subcutaneously for a period exceeding 3 months, for a total of 18 injections. The average level of IFN-γ and IL-17 was 2–2.5 times higher in the infected patients. This was not accompanied by an increase in TNF-α or IL-12 levels. A treatment with autovaccine eradicated S. aureus infection in 42 (84%) patients of group 2 and in 14 (35%) patients of group 3. A significant increase (two-fold) in IL-17A was observed in treated patients. Also, following the treatment with autovaccine, all patients demonstrated a significant increase in the levels of IFN-γ, TNF-α and IL-12. These studies showed for the first time that efficiency of the autovaccine treatment in patients with chronic S. aureus infection depends on an adequate secretory response of TH17 cells.
first_indexed 2024-12-11T06:37:06Z
format Article
id doaj.art-c2da2c11839147a3898b63ff5b5a25c7
institution Directory Open Access Journal
issn 1721-727X
language English
last_indexed 2024-12-11T06:37:06Z
publishDate 2013-01-01
publisher SAGE Publishing
record_format Article
series European Journal of Inflammation
spelling doaj.art-c2da2c11839147a3898b63ff5b5a25c72022-12-22T01:17:20ZengSAGE PublishingEuropean Journal of Inflammation1721-727X2013-01-011110.1177/1721727X1301100110Cytokine Response in Autovaccine-Treated Patients with Chronic InfectionsA. Szkaradkiewicz0T.M. Karpiński1O. Goślińska-Pawłowska2A.K. Szkaradkiewicz3S. Giedrys-Kalemba4 Department of Medical Microbiology, University of Medical Sciences in Poznan, Poland Department of Medical Microbiology, University of Medical Sciences in Poznan, Poland Department of Medical Microbiology, University of Medical Sciences in Poznan, Poland Department of Conservative Dentistry and Periodontology, University of Medical Sciences in Poznan, Poland Department of Microbiology and Immunology, Pomeranian Medical University, Szczecin, PolandThis study aims to describe the levels of circulating cytokines produced by Th lymphocytes (IFN-γ, IL-4, IL-10, IL-17A), as well as the levels of cytokines produced by monocytes/macrophages (TNF-α, IL-1β, IL-12), in patients with chronic Staphylococcus aureus infections before treatment and following completion of autovaccine treatment. The study was carried out on adult individuals, including 25 healthy subjects (group 1, control, not treated), 50 patients with chronic suppurative dermatitis (group 2) and 40 patients with chronic infections of the upper respiratory tract (group 3). Blood serum cytokine levels were measured by enzyme–linked immunosorbent assay (ELISA). S. aureus was detected in cultures of suppurative dermal exudates or of pharyngeal smears. For every individual patient an autovaccine was prepared, containing a suspension of inactivated S. aureus bacteria (1.5 × 10 8 bacteria/ml) isolated from the patient. The autovaccine was administered subcutaneously for a period exceeding 3 months, for a total of 18 injections. The average level of IFN-γ and IL-17 was 2–2.5 times higher in the infected patients. This was not accompanied by an increase in TNF-α or IL-12 levels. A treatment with autovaccine eradicated S. aureus infection in 42 (84%) patients of group 2 and in 14 (35%) patients of group 3. A significant increase (two-fold) in IL-17A was observed in treated patients. Also, following the treatment with autovaccine, all patients demonstrated a significant increase in the levels of IFN-γ, TNF-α and IL-12. These studies showed for the first time that efficiency of the autovaccine treatment in patients with chronic S. aureus infection depends on an adequate secretory response of TH17 cells.https://doi.org/10.1177/1721727X1301100110
spellingShingle A. Szkaradkiewicz
T.M. Karpiński
O. Goślińska-Pawłowska
A.K. Szkaradkiewicz
S. Giedrys-Kalemba
Cytokine Response in Autovaccine-Treated Patients with Chronic Infections
European Journal of Inflammation
title Cytokine Response in Autovaccine-Treated Patients with Chronic Infections
title_full Cytokine Response in Autovaccine-Treated Patients with Chronic Infections
title_fullStr Cytokine Response in Autovaccine-Treated Patients with Chronic Infections
title_full_unstemmed Cytokine Response in Autovaccine-Treated Patients with Chronic Infections
title_short Cytokine Response in Autovaccine-Treated Patients with Chronic Infections
title_sort cytokine response in autovaccine treated patients with chronic infections
url https://doi.org/10.1177/1721727X1301100110
work_keys_str_mv AT aszkaradkiewicz cytokineresponseinautovaccinetreatedpatientswithchronicinfections
AT tmkarpinski cytokineresponseinautovaccinetreatedpatientswithchronicinfections
AT ogoslinskapawłowska cytokineresponseinautovaccinetreatedpatientswithchronicinfections
AT akszkaradkiewicz cytokineresponseinautovaccinetreatedpatientswithchronicinfections
AT sgiedryskalemba cytokineresponseinautovaccinetreatedpatientswithchronicinfections